Related Experiment Video
Updated: May 15, 2026
Probe-based Confocal Laser Endomicroscopy of the Urinary Tract: The Technique
Published on: January 10, 2013
Nectin4-targeted molecular imaging for precise endoscopic diagnosis and image-guided surgery in bladder cancer
Yuhui He1, Haozhuo Guo2, Bing Wang3
1Department of Urology, China-Japan Friendship Hospital, Beijing 100029, China; Department of Urology, Peking University First Hospital, Beijing 100034, China; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
None:
Bladder cancer (BC) is a common malignancy, yet conventional white light cystoscopy (WLC) has suboptimal diagnostic accuracy. Nectin4, a membrane protein highly expressed in BC, is an attractive molecular imaging target. By conjugating indocyanine green (ICG) to enfortumab vedotin, we develop NECTIN4-ICG, a BC-specific fluorescence imaging probe. In BC mouse models, NECTIN4-ICG enables targeted detection and doubles the complete tumor resection rate. In an ex vivo study of 18 fresh human bladders yielding 82 specimens, NECTIN4-ICG-guided biopsy achieves 96.3% diagnostic accuracy. In a clinical trial involving 20 patients yielding 198 specimens, NECTIN4-ICG-guided biopsy achieves 96.0% diagnostic accuracy and 91.1% tumor margin detection, outperforming WLC (82.2% and 73.3%). NECTIN4-ICG also enables fluorescence-guided TURBT, enhancing real-time visualization, margin assessment, and carcinoma in situ detection with a favorable safety profile. This clinical trial is registered under ChiCTR2200067094 and ChiCTR2400092677.
